{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T23:06:20Z","timestamp":1780527980699,"version":"3.54.1"},"reference-count":23,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T00:00:00Z","timestamp":1776729600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"},{"start":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000},"content-version":"vor","delay-in-days":44,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["BMC Infect Dis"],"DOI":"10.1186\/s12879-026-13360-0","type":"journal-article","created":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T10:34:29Z","timestamp":1776767669000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":0,"title":["Interferon-gamma autoantibodies in patients with infectious uveitis: a pilot case\u2013control study"],"prefix":"10.1186","volume":"26","author":[{"given":"Apichaya","family":"Opasatian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chatchai","family":"Tayapiwatana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weeraya","family":"Thongkum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umpa","family":"Yasamut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kessara","family":"Pathanapitoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,4,21]]},"reference":[{"issue":"8","key":"13360_CR1","doi-asserted-by":"publisher","first-page":"725","DOI":"10.1056\/NEJMoa1111160","volume":"367","author":"SK Browne","year":"2012","unstructured":"Browne SK, Burbelo PD, Chetchotisakd P, Suputtamongkol Y, Kiertiburanakul S, Shaw PA, et al. Adult-onset immunodeficiency in Thailand and Taiwan. N Engl J Med. 2012;367(8):725\u201334.","journal-title":"N Engl J Med"},{"issue":"9","key":"13360_CR2","doi-asserted-by":"publisher","first-page":"e76371","DOI":"10.1371\/journal.pone.0076371","volume":"8","author":"P Wongkulab","year":"2013","unstructured":"Wongkulab P, Wipasa J, Chaiwarith R, Supparatpinyo K. Autoantibody to interferon-gamma associated with adult-onset immunodeficiency in non-HIV individuals in northern Thailand. PLoS ONE. 2013;8(9):e76371.","journal-title":"PLoS ONE"},{"issue":"1","key":"13360_CR3","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1093\/cid\/ciz786","volume":"71","author":"GH Hong","year":"2020","unstructured":"Hong GH, Ortega-Villa AM, Hunsberger S, Chetchotisakd P, Anunnatsiri S, Mootsikapun P, et al. Natural history and evolution of anti\u2013interferon-gamma autoantibody\u2013associated immunodeficiency syndrome in Thailand and the United States. Clin Infect Dis. 2020;71(1):53\u201362.","journal-title":"Clin Infect Dis"},{"issue":"8","key":"13360_CR4","doi-asserted-by":"publisher","first-page":"742","DOI":"10.2340\/00015555-2959","volume":"98","author":"K Jutivorakool","year":"2018","unstructured":"Jutivorakool K, Sittiwattanawong P, Kantikosum K, Hurst CP, Kumtornrut C, Asawanonda P, et al. Skin manifestations in patients with adult-onset immunodeficiency due to anti\u2013interferon-gamma autoantibody: a relationship with systemic infections. Acta Derm Venereol. 2018;98(8):742\u20137.","journal-title":"Acta Derm Venereol"},{"issue":"1","key":"13360_CR5","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/v15010185","volume":"15","author":"J Zhang","year":"2023","unstructured":"Zhang J, Kamoi K, Zong Y, Yang M, Ohno-Matsui K. Cytomegalovirus anterior uveitis: clinical manifestations, diagnosis, treatment, and immunological mechanisms. Viruses. 2023;15(1):1\u201317.","journal-title":"Viruses"},{"issue":"7","key":"13360_CR6","doi-asserted-by":"publisher","first-page":"1358","DOI":"10.1016\/j.ophtha.2006.09.035","volume":"114","author":"LA van Boxtel","year":"2007","unstructured":"van Boxtel LA, van der Lelij A, van der Meer J, Los LI. Cytomegalovirus as a cause of anterior uveitis in immunocompetent patients. Ophthalmology. 2007;114(7):1358\u201362.","journal-title":"Ophthalmology"},{"issue":"3","key":"13360_CR7","doi-asserted-by":"publisher","first-page":"320","DOI":"10.1111\/ceo.13417","volume":"47","author":"NS Chan","year":"2019","unstructured":"Chan NS, Chee SP. Demystifying viral anterior uveitis: a review. Clin Exp Ophthalmol. 2019;47(3):320\u201333.","journal-title":"Clin Exp Ophthalmol"},{"issue":"11","key":"13360_CR8","doi-asserted-by":"publisher","first-page":"2014","DOI":"10.1038\/s41433-024-02966-w","volume":"38","author":"G Clare","year":"2024","unstructured":"Clare G, Kempen JH, Pavesio C. Infectious eye disease in the twenty-first century\u2014an overview. Eye (Lond). 2024;38(11):2014\u201327.","journal-title":"Eye (Lond)"},{"key":"13360_CR9","doi-asserted-by":"publisher","first-page":"1117412","DOI":"10.3389\/fpubh.2023.1117412","volume":"11","author":"Z Ye","year":"2023","unstructured":"Ye Z, Yang Y, Ke W, Li Y, Wang K, Chen M. Overview and update on cytomegalovirus-associated anterior uveitis and glaucoma. Front Public Health. 2023;11:1117412.","journal-title":"Front Public Health"},{"issue":"4","key":"13360_CR10","doi-asserted-by":"publisher","first-page":"529","DOI":"10.1038\/eye.2011.363","volume":"26","author":"N Kongyai","year":"2012","unstructured":"Kongyai N, Sirirungsi W, Pathanapitoon K, Tananuvat N, Kunavisarut P, Leechanachai P, et al. Viral causes of unexplained anterior uveitis in Thailand. Eye (Lond). 2012;26(4):529\u201334.","journal-title":"Eye (Lond)"},{"issue":"1","key":"13360_CR11","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1080\/09273940802553816","volume":"17","author":"W Sirirungsi","year":"2009","unstructured":"Sirirungsi W, Pathanapitoon K, Kongyai N, Weersink A, de Groot-Mijnes JD, Leechanachai P, et al. Infectious uveitis in Thailand: serologic analyses and clinical features. Ocul Immunol Inflamm. 2009;17(1):17\u201322.","journal-title":"Ocul Immunol Inflamm"},{"key":"13360_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fimmu.2019.01905","volume":"10","author":"U Yasamut","year":"2019","unstructured":"Yasamut U, Thongkum W, Moonmuang S, Sakkhachornphop S, Chaiwarith R, Praparattanapan J, et al. Neutralizing activity of anti\u2013interferon-gamma autoantibodies in adult-onset immunodeficiency is associated with their binding domains. Front Immunol. 2019;10:1\u201312.","journal-title":"Front Immunol"},{"issue":"4","key":"13360_CR13","doi-asserted-by":"publisher","first-page":"e0215581","DOI":"10.1371\/journal.pone.0215581","volume":"14","author":"N Angkasekwinai","year":"2019","unstructured":"Angkasekwinai N, Suputtamongkol Y, Phoompoung P, Pithukpakorn M, Wongswat E, Umrod P, et al. Clinical outcome and laboratory markers for predicting disease activity in patients with disseminated opportunistic infections associated with anti\u2013interferon-gamma autoantibodies. PLoS ONE. 2019;14(4):e0215581.","journal-title":"PLoS ONE"},{"issue":"2","key":"13360_CR14","doi-asserted-by":"publisher","first-page":"163","DOI":"10.1189\/jlb.0603252","volume":"75","author":"K Schroder","year":"2004","unstructured":"Schroder K, Hertzog PJ, Ravasi T, Hume DA. Interferon-gamma: an overview of signals, mechanisms and functions. J Leukoc Biol. 2004;75(2):163\u201389.","journal-title":"J Leukoc Biol"},{"issue":"1","key":"13360_CR15","doi-asserted-by":"publisher","first-page":"5682","DOI":"10.1038\/s41598-019-41952-1","volume":"9","author":"DI Krisnawati","year":"2019","unstructured":"Krisnawati DI, Liu YC, Lee YJ, Wang YT, Chen CL, Tseng PC, et al. Functional neutralization of anti\u2013IFN-gamma autoantibody in patients with nontuberculous mycobacteria infection. Sci Rep. 2019;9(1):5682.","journal-title":"Sci Rep"},{"key":"13360_CR16","doi-asserted-by":"publisher","first-page":"1097514","DOI":"10.3389\/fmed.2022.1097514","volume":"9","author":"PK Chen","year":"2022","unstructured":"Chen PK, Liao TL, Chang SH, Yeo KJ, Chou CH, Chen DY. High-titer anti\u2013interferon-gamma neutralizing autoantibodies linked to opportunistic infections in patients with adult-onset Still\u2019s disease. Front Med (Lausanne). 2022;9:1097514.","journal-title":"Front Med (Lausanne)"},{"issue":"1","key":"13360_CR17","doi-asserted-by":"publisher","first-page":"87","DOI":"10.31524\/bkkmedj.2017.02.015","volume":"13","author":"W Laisuan","year":"2017","unstructured":"Laisuan W, Wongsa C, Intapiboon P, Dechapaphapeaktak N, Tongdee M, Oncham S, et al. Adult-onset immunodeficiency associated with anti\u2013interferon-gamma autoantibodies. Bangkok Med J. 2017;13(1):87\u201392.","journal-title":"Bangkok Med J"},{"issue":"4","key":"13360_CR18","doi-asserted-by":"publisher","first-page":"1033","DOI":"10.1093\/cid\/ciad676","volume":"78","author":"N Angkasekwinai","year":"2024","unstructured":"Angkasekwinai N, Suputtamongkol Y, Tantibhedhyangkul W, Onlamoon N, Phoompoung P, Pithukpakorn M, et al. Efficacy of bortezomib for treating anti\u2013interferon-gamma autoantibody\u2013associated adult-onset immunodeficiency syndrome. Clin Infect Dis. 2024;78(4):1033\u201342.","journal-title":"Clin Infect Dis"},{"key":"13360_CR19","doi-asserted-by":"publisher","first-page":"788368","DOI":"10.3389\/fimmu.2021.788368","volume":"12","author":"LF Chen","year":"2021","unstructured":"Chen LF, Yang CD, Cheng XB. Anti-interferon autoantibodies in adult-onset immunodeficiency syndrome and severe COVID-19 infection. Front Immunol. 2021;12:788368.","journal-title":"Front Immunol"},{"issue":"7","key":"13360_CR20","doi-asserted-by":"publisher","first-page":"1660","DOI":"10.1007\/s10875-023-01537-0","volume":"43","author":"B Zhang","year":"2023","unstructured":"Zhang B, Fan J, Huang C, Fan H, Chen J, Huang X, et al. Characteristics and outcomes of anti\u2013interferon-gamma antibody\u2013associated adult-onset immunodeficiency. J Clin Immunol. 2023;43(7):1660\u201370.","journal-title":"J Clin Immunol"},{"issue":"8","key":"13360_CR21","doi-asserted-by":"publisher","first-page":"1357","DOI":"10.1182\/blood-2012-08-452482","volume":"121","author":"CY Chi","year":"2013","unstructured":"Chi CY, Chu CC, Liu JP, et al. Anti-IFN-gamma autoantibodies in adults with disseminated nontuberculous mycobacterial infections are associated with HLA-DRB1*16:02 and HLA-DQB1*05:02 and the reactivation of latent varicella-zoster virus infection. Blood. 2013;121(8):1357\u201366.","journal-title":"Blood"},{"issue":"3","key":"13360_CR22","doi-asserted-by":"publisher","first-page":"945","DOI":"10.1016\/j.jaci.2015.09.018","volume":"137","author":"CL Ku","year":"2016","unstructured":"Ku CL, Lin CH, Chang SW, et al. Anti-IFN-gamma autoantibodies are strongly associated with HLA-DR*15:02\/16:02 and HLA-DQ*05:01\/05:02 across Southeast Asia. J Allergy Clin Immunol. 2016;137(3):945\u2013e88.","journal-title":"J Allergy Clin Immunol"},{"issue":"1","key":"13360_CR23","doi-asserted-by":"publisher","first-page":"9069","DOI":"10.1038\/s41598-022-13160-x","volume":"12","author":"Y Qiu","year":"2022","unstructured":"Qiu Y, Tang M, Zeng W, et al. Clinical findings and predictive factors for positive anti-interferon-gamma autoantibodies in patients suffering from a non-tuberculosis mycobacterium or Talaromyces marneffei infection: a multicenter prospective cohort study. Sci Rep. 2022;12(1):9069.","journal-title":"Sci Rep"}],"container-title":["BMC Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/article\/10.1186\/s12879-026-13360-0","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13360-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s12879-026-13360-0.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T22:25:45Z","timestamp":1780525545000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1186\/s12879-026-13360-0"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,4,21]]},"references-count":23,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2026,12]]}},"alternative-id":["13360"],"URL":"https:\/\/doi.org\/10.1186\/s12879-026-13360-0","relation":{},"ISSN":["1471-2334"],"issn-type":[{"value":"1471-2334","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,4,21]]},"assertion":[{"value":"18 December 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"14 April 2026","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"21 April 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Ethics approval for this study was obtained from the Research Ethics Committee Panel 5, Faculty of Medicine, Chiang Mai University, Thailand (Approval No.167\/2024). All participants provided written informed consent prior to enrollment. For the control group, deidentified serum samples were obtained from the institutional blood bank; all blood donors provided consent at the time of donation for secondary use of anonymized samples for research. All procedures were performed in accordance with the Declaration of Helsinki and local regulatory requirements.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethics approval and consent to participate"}},{"value":"Consent for publication was not required because all clinical images included in this manuscript are fully anonymized and do not contain any identifiable personal information, in accordance with the policies of BMC and the Research Ethics Committee of the Faculty of Medicine, Chiang Mai University.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Consent for publication"}},{"value":"The authors declare no competing interests.","order":4,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}],"article-number":"1071"}}